MBX Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
MBX Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q3 2024.
  • MBX Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$18.1M, a 78.5% decline year-over-year.
  • MBX Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$55.2M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$55.2M -$18.1M -$7.98M -78.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$47.2M -$15.9M -$8.25M -108% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$39M -$12.3M -$6.39M -107% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$32.6M -$8.88M Oct 1, 2023 Dec 31, 2023 10-Q 2024-11-07
Q3 2023 -$10.2M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$7.61M Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$5.95M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.